The mTOR inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo

Böhm M, Stegemann A, Metze D, Scharffetter-Kochanek K, Sindrilaru A

Research article (journal) | Peer reviewed

Details about the publication

JournalBritish Journal of Dermatology (Br J Dermatol)
Volumen/a
StatusPublished
Release year2017
Language in which the publication is writtenEnglish
DOI10.1111/bjd.15421

Authors from the University of Münster

Metze, Dieter
Clinic for Dermatology